Skip to main content

LFTD Partners Inc.

LIFD
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001391135

No open-market purchases or sales by LFTD Partners Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Key figures

Insider buysOpen market, last 90 days
0
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026
0
13F valueReported value at the end of Q2 2026
$0
Superinvestors holdingAt the end of Q2 2026
0

Price chart

Superinvestors holding LIFD, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding LIFD at the end of Q2 2026.

Latest insider trades

Open-market purchases and sales by LFTD Partners Inc. insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 21, 2023 (view filing)Nov 156 daysJacobs Gerard M.CEOPPurchase+375$1.50+$562.50.0%1.06M afterAmended

Top 10 13F holders, Q2 2026

The largest institutional positions in LFTD Partners Inc. at the end of Q2 2026; share changes are against Q1 2026.

View all: Top 10 13F holders, Q2 2026

No institution reported holding LIFD in 13F filings for Q2 2026.